Cygene Standard Testing Policies

Conventional DNA tests, based solely on target amplification technology, are limited to evaluating small sample sizes per test, a practice which leads to potential false negatives. This genetic testing process is like searching only a small amount of hay to find the proverbial "needle in the haystack."

In that sense, CyGene's Haystack ProcessingTM dna analysis methodology can be compared with searching the entire haystack for the needle. Using proprietary or conventional target isolation technologies, combined with signal amplification post-target isolation detection methods, Haystack genetic testing Processing can locate the presence of "extremely rare targets." This method further reduces false negative results.

CyGene's Haystack Processing technology, coupled with AGENDATM, the Company's proprietary robotic platform for genomic analysis, allows life sciences to evolve from the research lab to the commercial marketplace.

CyGene's proprietary Haystack Processing methods have several benefits:

  • They offer the ability to test a large sample size, increasing sensitivity
  • The target capture methods increase specificity of results, reducing false positive results
  • They allow the detection of disease-causing entities at the earliest point in the infection time-course for pro-active results
  • They facilitate the monitoring of the patient during therapeutic treatment, allowing for drug modulation based on the patient's response to the drug
  • The development of fully automated methods for Haystack Processing will lead to the use of these technologies in point-of-care applications (such as hospitals, doctors and veterinary offices, and water treatment plantsworldwide)
  • After the initial diagnosis, Haystack Processing allows for the monitoring of the therapeutic process by helping to determine the anticipated reduction in viral or other disease load in the patient. CyGene's pharmacogenomic genetic profiling provides customized information about what drugs to use and which ones will be metabolized best.

© Copyright 2009, CyGene Laboratories Inc. All rights reserved. CyGene DIRECT and CyGene Laboratories are registered trademarks of CyGene Laboratories.
CyGene Laboratories Receives CLIA Laboratory Registration. The State of Florida Agency for Health Care Administration has provided CyGene with a certificate that will allow its lab to perform clinical diagnostic testing. Learn More

About This Page: CyGene uses proprietary dna analysis methods & genetic testing process or conventional target isolation technologies, combined with signal amplification post-target isolation detection dna analysis methods. Our DNA test process, Haystack Processing can locate the presence of extremely rare targets. This DNA analysis method further reduces false negative results.